nodes	percent_of_prediction	percent_of_DWPC	metapath
Diclofenac—ALOX5—stomach cancer	0.174	0.438	CbGaD
Diclofenac—CXCL8—stomach cancer	0.144	0.362	CbGaD
Diclofenac—PTGS2—stomach cancer	0.0419	0.106	CbGaD
Diclofenac—ALB—stomach cancer	0.0374	0.0942	CbGaD
Diclofenac—UGT2B7—Epirubicin—stomach cancer	0.0308	0.0893	CbGbCtD
Diclofenac—SLCO1C1—Methotrexate—stomach cancer	0.0292	0.0846	CbGbCtD
Diclofenac—UGT1A1—Irinotecan—stomach cancer	0.0259	0.0751	CbGbCtD
Diclofenac—ABCC4—Fluorouracil—stomach cancer	0.0254	0.0737	CbGbCtD
Diclofenac—ABCC1—Epirubicin—stomach cancer	0.0219	0.0634	CbGbCtD
Diclofenac—ABCC1—Irinotecan—stomach cancer	0.0213	0.0617	CbGbCtD
Diclofenac—ABCB1—Mitomycin—stomach cancer	0.02	0.058	CbGbCtD
Diclofenac—ABCC1—Docetaxel—stomach cancer	0.0156	0.0452	CbGbCtD
Diclofenac—SLC22A11—Methotrexate—stomach cancer	0.0151	0.0437	CbGbCtD
Diclofenac—ABCC4—Methotrexate—stomach cancer	0.014	0.0406	CbGbCtD
Diclofenac—ABCC1—Doxorubicin—stomach cancer	0.0116	0.0337	CbGbCtD
Diclofenac—ABCC1—Methotrexate—stomach cancer	0.0113	0.0327	CbGbCtD
Diclofenac—CYP2B6—Irinotecan—stomach cancer	0.01	0.029	CbGbCtD
Diclofenac—ALB—Irinotecan—stomach cancer	0.00983	0.0285	CbGbCtD
Diclofenac—ALB—Fluorouracil—stomach cancer	0.00943	0.0273	CbGbCtD
Diclofenac—SLC22A8—Methotrexate—stomach cancer	0.00877	0.0254	CbGbCtD
Diclofenac—CYP2C9—Capecitabine—stomach cancer	0.00857	0.0248	CbGbCtD
Diclofenac—CYP2C8—Fluorouracil—stomach cancer	0.00729	0.0211	CbGbCtD
Diclofenac—SLC22A6—Methotrexate—stomach cancer	0.00611	0.0177	CbGbCtD
Diclofenac—CYP1A2—Fluorouracil—stomach cancer	0.00564	0.0163	CbGbCtD
Diclofenac—CYP2B6—Doxorubicin—stomach cancer	0.00548	0.0159	CbGbCtD
Diclofenac—ALB—Methotrexate—stomach cancer	0.0052	0.0151	CbGbCtD
Diclofenac—ABCB1—Irinotecan—stomach cancer	0.00514	0.0149	CbGbCtD
Diclofenac—CYP2C9—Fluorouracil—stomach cancer	0.00508	0.0147	CbGbCtD
Diclofenac—ABCB1—Docetaxel—stomach cancer	0.00377	0.0109	CbGbCtD
Diclofenac—CYP3A4—Irinotecan—stomach cancer	0.00308	0.00892	CbGbCtD
Diclofenac—ABCB1—Doxorubicin—stomach cancer	0.00281	0.00814	CbGbCtD
Diclofenac—ABCB1—Methotrexate—stomach cancer	0.00272	0.00788	CbGbCtD
Diclofenac—CYP3A4—Docetaxel—stomach cancer	0.00226	0.00654	CbGbCtD
Diclofenac—CYP3A4—Doxorubicin—stomach cancer	0.00168	0.00487	CbGbCtD
Diclofenac—CXCR1—bone marrow—stomach cancer	0.00163	0.0373	CbGeAlD
Diclofenac—CXCR1—lymph node—stomach cancer	0.00101	0.0231	CbGeAlD
Diclofenac—PLA2G2A—hematopoietic system—stomach cancer	0.00091	0.0208	CbGeAlD
Diclofenac—ASIC1—endocrine gland—stomach cancer	0.000867	0.0199	CbGeAlD
Diclofenac—Meclofenamic acid—AKR1C3—stomach cancer	0.00085	0.284	CrCbGaD
Diclofenac—PLA2G2A—epithelium—stomach cancer	0.000832	0.019	CbGeAlD
Diclofenac—PLA2G2A—smooth muscle tissue—stomach cancer	0.000801	0.0183	CbGeAlD
Diclofenac—CXCL8—smooth muscle tissue—stomach cancer	0.000793	0.0182	CbGeAlD
Diclofenac—ALB—gall bladder—stomach cancer	0.000775	0.0177	CbGeAlD
Diclofenac—PLA2G2A—pancreas—stomach cancer	0.000741	0.017	CbGeAlD
Diclofenac—CXCL8—pancreas—stomach cancer	0.000733	0.0168	CbGeAlD
Diclofenac—TTR—hematopoietic system—stomach cancer	0.000687	0.0157	CbGeAlD
Diclofenac—Mefenamic acid—AKR1C3—stomach cancer	0.000661	0.221	CrCbGaD
Diclofenac—UGT1A1—hematopoietic system—stomach cancer	0.000651	0.0149	CbGeAlD
Diclofenac—PLA2G2A—lymphoid tissue—stomach cancer	0.00064	0.0147	CbGeAlD
Diclofenac—KCNQ2—endocrine gland—stomach cancer	0.000635	0.0145	CbGeAlD
Diclofenac—PLA2G2A—digestive system—stomach cancer	0.000633	0.0145	CbGeAlD
Diclofenac—ALOX5—hematopoietic system—stomach cancer	0.000622	0.0143	CbGeAlD
Diclofenac—Meclofenamic acid—ALOX5—stomach cancer	0.000617	0.206	CrCbGaD
Diclofenac—ASIC1—lymph node—stomach cancer	0.0006	0.0137	CbGeAlD
Diclofenac—CYP2C18—digestive system—stomach cancer	0.000577	0.0132	CbGeAlD
Diclofenac—CXCL8—bone marrow—stomach cancer	0.000577	0.0132	CbGeAlD
Diclofenac—TTR—pancreas—stomach cancer	0.000559	0.0128	CbGeAlD
Diclofenac—ALOX5—smooth muscle tissue—stomach cancer	0.000548	0.0126	CbGeAlD
Diclofenac—UGT2B7—digestive system—stomach cancer	0.000533	0.0122	CbGeAlD
Diclofenac—PLA2G2A—endocrine gland—stomach cancer	0.000523	0.012	CbGeAlD
Diclofenac—SLC22A11—digestive system—stomach cancer	0.000519	0.0119	CbGeAlD
Diclofenac—ALOX5—pancreas—stomach cancer	0.000507	0.0116	CbGeAlD
Diclofenac—TTR—lymphoid tissue—stomach cancer	0.000484	0.0111	CbGeAlD
Diclofenac—TTR—digestive system—stomach cancer	0.000478	0.0109	CbGeAlD
Diclofenac—CYP2C18—endocrine gland—stomach cancer	0.000477	0.0109	CbGeAlD
Diclofenac—PLA2G2A—liver—stomach cancer	0.000471	0.0108	CbGeAlD
Diclofenac—PTGS1—blood vessel—stomach cancer	0.000469	0.0107	CbGeAlD
Diclofenac—CXCL8—liver—stomach cancer	0.000467	0.0107	CbGeAlD
Diclofenac—UGT1A1—digestive system—stomach cancer	0.000453	0.0104	CbGeAlD
Diclofenac—PTGS2—blood vessel—stomach cancer	0.000448	0.0103	CbGeAlD
Diclofenac—SLCO1C1—endocrine gland—stomach cancer	0.000442	0.0101	CbGeAlD
Diclofenac—TTR—bone marrow—stomach cancer	0.00044	0.0101	CbGeAlD
Diclofenac—UGT2B7—endocrine gland—stomach cancer	0.00044	0.0101	CbGeAlD
Diclofenac—ALOX5—lymphoid tissue—stomach cancer	0.000438	0.01	CbGeAlD
Diclofenac—ALOX5—digestive system—stomach cancer	0.000433	0.00991	CbGeAlD
Diclofenac—CYP2C18—liver—stomach cancer	0.00043	0.00985	CbGeAlD
Diclofenac—SLC22A11—endocrine gland—stomach cancer	0.000429	0.00982	CbGeAlD
Diclofenac—ABCC4—hematopoietic system—stomach cancer	0.000424	0.00972	CbGeAlD
Diclofenac—PTGS2—gall bladder—stomach cancer	0.000422	0.00966	CbGeAlD
Diclofenac—SLC22A8—hematopoietic system—stomach cancer	0.000421	0.00964	CbGeAlD
Diclofenac—ALOX5—bone marrow—stomach cancer	0.000399	0.00914	CbGeAlD
Diclofenac—UGT2B7—liver—stomach cancer	0.000397	0.00908	CbGeAlD
Diclofenac—TTR—endocrine gland—stomach cancer	0.000395	0.00904	CbGeAlD
Diclofenac—SLC22A11—liver—stomach cancer	0.000387	0.00885	CbGeAlD
Diclofenac—UGT1A1—endocrine gland—stomach cancer	0.000374	0.00857	CbGeAlD
Diclofenac—PLA2G2A—lymph node—stomach cancer	0.000361	0.00827	CbGeAlD
Diclofenac—CXCL8—lymph node—stomach cancer	0.000358	0.00819	CbGeAlD
Diclofenac—ALOX5—endocrine gland—stomach cancer	0.000358	0.00819	CbGeAlD
Diclofenac—TTR—liver—stomach cancer	0.000356	0.00815	CbGeAlD
Diclofenac—CYP2C19—hematopoietic system—stomach cancer	0.000353	0.00808	CbGeAlD
Diclofenac—ABCC4—pancreas—stomach cancer	0.000346	0.00791	CbGeAlD
Diclofenac—UGT1A1—liver—stomach cancer	0.000337	0.00772	CbGeAlD
Diclofenac—ALOX5—liver—stomach cancer	0.000322	0.00738	CbGeAlD
Diclofenac—CYP2C8—hematopoietic system—stomach cancer	0.000308	0.00705	CbGeAlD
Diclofenac—SLCO1C1—lymph node—stomach cancer	0.000305	0.00699	CbGeAlD
Diclofenac—ABCC4—digestive system—stomach cancer	0.000295	0.00676	CbGeAlD
Diclofenac—CYP1A2—hematopoietic system—stomach cancer	0.000288	0.0066	CbGeAlD
Diclofenac—CYP1A1—hematopoietic system—stomach cancer	0.000284	0.00651	CbGeAlD
Diclofenac—ABCB1—blood vessel—stomach cancer	0.000277	0.00635	CbGeAlD
Diclofenac—CYP2B6—hematopoietic system—stomach cancer	0.000276	0.00633	CbGeAlD
Diclofenac—CYP2C9—hematopoietic system—stomach cancer	0.000274	0.00627	CbGeAlD
Diclofenac—ABCC4—bone marrow—stomach cancer	0.000272	0.00623	CbGeAlD
Diclofenac—CYP1A1—epithelium—stomach cancer	0.00026	0.00595	CbGeAlD
Diclofenac—CYP2E1—hematopoietic system—stomach cancer	0.000259	0.00594	CbGeAlD
Diclofenac—PTGS1—hematopoietic system—stomach cancer	0.00025	0.00572	CbGeAlD
Diclofenac—ALOX5—lymph node—stomach cancer	0.000247	0.00566	CbGeAlD
Diclofenac—CYP2C19—digestive system—stomach cancer	0.000245	0.00562	CbGeAlD
Diclofenac—ABCC4—endocrine gland—stomach cancer	0.000244	0.00558	CbGeAlD
Diclofenac—PTGS2—hematopoietic system—stomach cancer	0.000239	0.00547	CbGeAlD
Diclofenac—PTGS1—epithelium—stomach cancer	0.000228	0.00523	CbGeAlD
Diclofenac—ALB—liver—stomach cancer	0.000227	0.0052	CbGeAlD
Diclofenac—Bromfenac—PTGS2—stomach cancer	0.000225	0.0752	CrCbGaD
Diclofenac—PTGS1—smooth muscle tissue—stomach cancer	0.00022	0.00504	CbGeAlD
Diclofenac—ABCC4—liver—stomach cancer	0.00022	0.00503	CbGeAlD
Diclofenac—PTGS2—epithelium—stomach cancer	0.000218	0.005	CbGeAlD
Diclofenac—PTGS2—smooth muscle tissue—stomach cancer	0.00021	0.00482	CbGeAlD
Diclofenac—CYP3A4—hematopoietic system—stomach cancer	0.000209	0.00478	CbGeAlD
Diclofenac—CYP2C19—endocrine gland—stomach cancer	0.000203	0.00464	CbGeAlD
Diclofenac—CYP1A2—digestive system—stomach cancer	0.0002	0.00459	CbGeAlD
Diclofenac—CYP1A1—digestive system—stomach cancer	0.000198	0.00453	CbGeAlD
Diclofenac—CYP2B6—lymphoid tissue—stomach cancer	0.000195	0.00445	CbGeAlD
Diclofenac—PTGS2—pancreas—stomach cancer	0.000194	0.00445	CbGeAlD
Diclofenac—CYP2B6—digestive system—stomach cancer	0.000192	0.0044	CbGeAlD
Diclofenac—Lumiracoxib—PTGS2—stomach cancer	0.000191	0.0639	CrCbGaD
Diclofenac—CYP2C9—digestive system—stomach cancer	0.00019	0.00436	CbGeAlD
Diclofenac—ABCC1—liver—stomach cancer	0.000187	0.00429	CbGeAlD
Diclofenac—CYP2C19—liver—stomach cancer	0.000183	0.00419	CbGeAlD
Diclofenac—CYP2E1—lymphoid tissue—stomach cancer	0.000183	0.00418	CbGeAlD
Diclofenac—Nepafenac—PTGS2—stomach cancer	0.000182	0.0608	CrCbGaD
Diclofenac—CYP2E1—digestive system—stomach cancer	0.00018	0.00413	CbGeAlD
Diclofenac—CYP2C8—endocrine gland—stomach cancer	0.000177	0.00405	CbGeAlD
Diclofenac—ALB—lymph node—stomach cancer	0.000174	0.00399	CbGeAlD
Diclofenac—PTGS1—digestive system—stomach cancer	0.000174	0.00398	CbGeAlD
Diclofenac—ABCC4—lymph node—stomach cancer	0.000169	0.00386	CbGeAlD
Diclofenac—PTGS2—lymphoid tissue—stomach cancer	0.000168	0.00385	CbGeAlD
Diclofenac—PTGS2—digestive system—stomach cancer	0.000166	0.0038	CbGeAlD
Diclofenac—CYP1A2—endocrine gland—stomach cancer	0.000166	0.00379	CbGeAlD
Diclofenac—CYP1A1—endocrine gland—stomach cancer	0.000163	0.00374	CbGeAlD
Diclofenac—CYP2C8—liver—stomach cancer	0.00016	0.00365	CbGeAlD
Diclofenac—CYP2B6—endocrine gland—stomach cancer	0.000159	0.00364	CbGeAlD
Diclofenac—CYP2C9—endocrine gland—stomach cancer	0.000157	0.0036	CbGeAlD
Diclofenac—PTGS2—bone marrow—stomach cancer	0.000153	0.00351	CbGeAlD
Diclofenac—CYP1A2—liver—stomach cancer	0.000149	0.00342	CbGeAlD
Diclofenac—Meclofenamic acid—PTGS2—stomach cancer	0.000149	0.0498	CrCbGaD
Diclofenac—CYP2E1—endocrine gland—stomach cancer	0.000149	0.00341	CbGeAlD
Diclofenac—ABCB1—hematopoietic system—stomach cancer	0.000148	0.00338	CbGeAlD
Diclofenac—CYP1A1—liver—stomach cancer	0.000147	0.00337	CbGeAlD
Diclofenac—CYP3A4—digestive system—stomach cancer	0.000145	0.00332	CbGeAlD
Diclofenac—ABCC1—lymph node—stomach cancer	0.000144	0.00329	CbGeAlD
Diclofenac—PTGS1—endocrine gland—stomach cancer	0.000144	0.00329	CbGeAlD
Diclofenac—CYP2B6—liver—stomach cancer	0.000143	0.00328	CbGeAlD
Diclofenac—CYP2C9—liver—stomach cancer	0.000142	0.00325	CbGeAlD
Diclofenac—PTGS2—endocrine gland—stomach cancer	0.000137	0.00314	CbGeAlD
Diclofenac—ABCB1—epithelium—stomach cancer	0.000135	0.00309	CbGeAlD
Diclofenac—CYP2E1—liver—stomach cancer	0.000134	0.00308	CbGeAlD
Diclofenac—PTGS2—liver—stomach cancer	0.000124	0.00283	CbGeAlD
Diclofenac—ABCB1—pancreas—stomach cancer	0.00012	0.00275	CbGeAlD
Diclofenac—CYP3A4—endocrine gland—stomach cancer	0.00012	0.00275	CbGeAlD
Diclofenac—Mefenamic acid—PTGS2—stomach cancer	0.000116	0.0387	CrCbGaD
Diclofenac—CYP1A1—lymph node—stomach cancer	0.000113	0.00259	CbGeAlD
Diclofenac—CYP3A4—liver—stomach cancer	0.000108	0.00248	CbGeAlD
Diclofenac—ABCB1—lymphoid tissue—stomach cancer	0.000104	0.00238	CbGeAlD
Diclofenac—ABCB1—digestive system—stomach cancer	0.000103	0.00235	CbGeAlD
Diclofenac—PTGS1—lymph node—stomach cancer	9.92e-05	0.00227	CbGeAlD
Diclofenac—PTGS2—lymph node—stomach cancer	9.49e-05	0.00217	CbGeAlD
Diclofenac—ABCB1—bone marrow—stomach cancer	9.47e-05	0.00217	CbGeAlD
Diclofenac—ABCB1—endocrine gland—stomach cancer	8.49e-05	0.00194	CbGeAlD
Diclofenac—ABCB1—liver—stomach cancer	7.65e-05	0.00175	CbGeAlD
Diclofenac—ABCB1—lymph node—stomach cancer	5.87e-05	0.00134	CbGeAlD
Diclofenac—Pharyngitis—Doxorubicin—stomach cancer	4.01e-05	0.000323	CcSEcCtD
Diclofenac—Paraesthesia—Capecitabine—stomach cancer	4e-05	0.000322	CcSEcCtD
Diclofenac—Decreased appetite—Docetaxel—stomach cancer	4e-05	0.000322	CcSEcCtD
Diclofenac—Headache—Fluorouracil—stomach cancer	4e-05	0.000322	CcSEcCtD
Diclofenac—Urinary tract disorder—Doxorubicin—stomach cancer	3.99e-05	0.000322	CcSEcCtD
Diclofenac—Oedema peripheral—Doxorubicin—stomach cancer	3.98e-05	0.000321	CcSEcCtD
Diclofenac—Dysgeusia—Methotrexate—stomach cancer	3.98e-05	0.000321	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Docetaxel—stomach cancer	3.97e-05	0.00032	CcSEcCtD
Diclofenac—Dyspnoea—Capecitabine—stomach cancer	3.97e-05	0.00032	CcSEcCtD
Diclofenac—Fatigue—Docetaxel—stomach cancer	3.97e-05	0.00032	CcSEcCtD
Diclofenac—Angiopathy—Epirubicin—stomach cancer	3.97e-05	0.000319	CcSEcCtD
Diclofenac—Urethral disorder—Doxorubicin—stomach cancer	3.96e-05	0.000319	CcSEcCtD
Diclofenac—Nausea—Irinotecan—stomach cancer	3.96e-05	0.000318	CcSEcCtD
Diclofenac—Immune system disorder—Epirubicin—stomach cancer	3.95e-05	0.000318	CcSEcCtD
Diclofenac—Mediastinal disorder—Epirubicin—stomach cancer	3.94e-05	0.000317	CcSEcCtD
Diclofenac—Pain—Docetaxel—stomach cancer	3.94e-05	0.000317	CcSEcCtD
Diclofenac—Constipation—Docetaxel—stomach cancer	3.94e-05	0.000317	CcSEcCtD
Diclofenac—Back pain—Methotrexate—stomach cancer	3.93e-05	0.000317	CcSEcCtD
Diclofenac—Dyspepsia—Capecitabine—stomach cancer	3.92e-05	0.000316	CcSEcCtD
Diclofenac—Chills—Epirubicin—stomach cancer	3.92e-05	0.000316	CcSEcCtD
Diclofenac—Arrhythmia—Epirubicin—stomach cancer	3.9e-05	0.000314	CcSEcCtD
Diclofenac—Visual impairment—Doxorubicin—stomach cancer	3.9e-05	0.000314	CcSEcCtD
Diclofenac—Decreased appetite—Capecitabine—stomach cancer	3.87e-05	0.000312	CcSEcCtD
Diclofenac—Alopecia—Epirubicin—stomach cancer	3.86e-05	0.000311	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Capecitabine—stomach cancer	3.85e-05	0.00031	CcSEcCtD
Diclofenac—Fatigue—Capecitabine—stomach cancer	3.84e-05	0.000309	CcSEcCtD
Diclofenac—Vision blurred—Methotrexate—stomach cancer	3.83e-05	0.000308	CcSEcCtD
Diclofenac—Mental disorder—Epirubicin—stomach cancer	3.83e-05	0.000308	CcSEcCtD
Diclofenac—Erythema multiforme—Doxorubicin—stomach cancer	3.82e-05	0.000308	CcSEcCtD
Diclofenac—Constipation—Capecitabine—stomach cancer	3.81e-05	0.000307	CcSEcCtD
Diclofenac—Pain—Capecitabine—stomach cancer	3.81e-05	0.000307	CcSEcCtD
Diclofenac—Malnutrition—Epirubicin—stomach cancer	3.8e-05	0.000306	CcSEcCtD
Diclofenac—Erythema—Epirubicin—stomach cancer	3.8e-05	0.000306	CcSEcCtD
Diclofenac—Feeling abnormal—Docetaxel—stomach cancer	3.79e-05	0.000305	CcSEcCtD
Diclofenac—Nausea—Fluorouracil—stomach cancer	3.79e-05	0.000305	CcSEcCtD
Diclofenac—Eye disorder—Doxorubicin—stomach cancer	3.78e-05	0.000304	CcSEcCtD
Diclofenac—Ill-defined disorder—Methotrexate—stomach cancer	3.77e-05	0.000304	CcSEcCtD
Diclofenac—Tinnitus—Doxorubicin—stomach cancer	3.77e-05	0.000304	CcSEcCtD
Diclofenac—Gastrointestinal pain—Docetaxel—stomach cancer	3.76e-05	0.000303	CcSEcCtD
Diclofenac—Anaemia—Methotrexate—stomach cancer	3.76e-05	0.000303	CcSEcCtD
Diclofenac—Cardiac disorder—Doxorubicin—stomach cancer	3.75e-05	0.000302	CcSEcCtD
Diclofenac—Flushing—Doxorubicin—stomach cancer	3.75e-05	0.000302	CcSEcCtD
Diclofenac—Flatulence—Epirubicin—stomach cancer	3.75e-05	0.000302	CcSEcCtD
Diclofenac—Tension—Epirubicin—stomach cancer	3.73e-05	0.000301	CcSEcCtD
Diclofenac—Dysgeusia—Epirubicin—stomach cancer	3.73e-05	0.0003	CcSEcCtD
Diclofenac—Nervousness—Epirubicin—stomach cancer	3.7e-05	0.000298	CcSEcCtD
Diclofenac—Back pain—Epirubicin—stomach cancer	3.68e-05	0.000296	CcSEcCtD
Diclofenac—Feeling abnormal—Capecitabine—stomach cancer	3.67e-05	0.000296	CcSEcCtD
Diclofenac—Angiopathy—Doxorubicin—stomach cancer	3.67e-05	0.000295	CcSEcCtD
Diclofenac—Malaise—Methotrexate—stomach cancer	3.67e-05	0.000295	CcSEcCtD
Diclofenac—Muscle spasms—Epirubicin—stomach cancer	3.66e-05	0.000294	CcSEcCtD
Diclofenac—Immune system disorder—Doxorubicin—stomach cancer	3.65e-05	0.000294	CcSEcCtD
Diclofenac—Vertigo—Methotrexate—stomach cancer	3.65e-05	0.000294	CcSEcCtD
Diclofenac—Gastrointestinal pain—Capecitabine—stomach cancer	3.64e-05	0.000293	CcSEcCtD
Diclofenac—Mediastinal disorder—Doxorubicin—stomach cancer	3.64e-05	0.000293	CcSEcCtD
Diclofenac—Abdominal pain—Docetaxel—stomach cancer	3.64e-05	0.000293	CcSEcCtD
Diclofenac—Body temperature increased—Docetaxel—stomach cancer	3.64e-05	0.000293	CcSEcCtD
Diclofenac—Leukopenia—Methotrexate—stomach cancer	3.64e-05	0.000293	CcSEcCtD
Diclofenac—Chills—Doxorubicin—stomach cancer	3.63e-05	0.000292	CcSEcCtD
Diclofenac—Arrhythmia—Doxorubicin—stomach cancer	3.61e-05	0.000291	CcSEcCtD
Diclofenac—Vision blurred—Epirubicin—stomach cancer	3.59e-05	0.000289	CcSEcCtD
Diclofenac—Alopecia—Doxorubicin—stomach cancer	3.57e-05	0.000288	CcSEcCtD
Diclofenac—Cough—Methotrexate—stomach cancer	3.55e-05	0.000286	CcSEcCtD
Diclofenac—Mental disorder—Doxorubicin—stomach cancer	3.54e-05	0.000285	CcSEcCtD
Diclofenac—Urticaria—Capecitabine—stomach cancer	3.54e-05	0.000285	CcSEcCtD
Diclofenac—Ill-defined disorder—Epirubicin—stomach cancer	3.53e-05	0.000284	CcSEcCtD
Diclofenac—Abdominal pain—Capecitabine—stomach cancer	3.52e-05	0.000284	CcSEcCtD
Diclofenac—Body temperature increased—Capecitabine—stomach cancer	3.52e-05	0.000284	CcSEcCtD
Diclofenac—Convulsion—Methotrexate—stomach cancer	3.52e-05	0.000284	CcSEcCtD
Diclofenac—Erythema—Doxorubicin—stomach cancer	3.52e-05	0.000283	CcSEcCtD
Diclofenac—Malnutrition—Doxorubicin—stomach cancer	3.52e-05	0.000283	CcSEcCtD
Diclofenac—Anaemia—Epirubicin—stomach cancer	3.52e-05	0.000283	CcSEcCtD
Diclofenac—Agitation—Epirubicin—stomach cancer	3.5e-05	0.000281	CcSEcCtD
Diclofenac—Flatulence—Doxorubicin—stomach cancer	3.47e-05	0.000279	CcSEcCtD
Diclofenac—Arthralgia—Methotrexate—stomach cancer	3.46e-05	0.000279	CcSEcCtD
Diclofenac—Myalgia—Methotrexate—stomach cancer	3.46e-05	0.000279	CcSEcCtD
Diclofenac—Chest pain—Methotrexate—stomach cancer	3.46e-05	0.000279	CcSEcCtD
Diclofenac—Tension—Doxorubicin—stomach cancer	3.45e-05	0.000278	CcSEcCtD
Diclofenac—Dysgeusia—Doxorubicin—stomach cancer	3.45e-05	0.000278	CcSEcCtD
Diclofenac—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	3.44e-05	0.000277	CcSEcCtD
Diclofenac—Malaise—Epirubicin—stomach cancer	3.43e-05	0.000276	CcSEcCtD
Diclofenac—Discomfort—Methotrexate—stomach cancer	3.42e-05	0.000275	CcSEcCtD
Diclofenac—Nervousness—Doxorubicin—stomach cancer	3.42e-05	0.000275	CcSEcCtD
Diclofenac—Vertigo—Epirubicin—stomach cancer	3.42e-05	0.000275	CcSEcCtD
Diclofenac—Syncope—Epirubicin—stomach cancer	3.41e-05	0.000275	CcSEcCtD
Diclofenac—Leukopenia—Epirubicin—stomach cancer	3.41e-05	0.000274	CcSEcCtD
Diclofenac—Back pain—Doxorubicin—stomach cancer	3.41e-05	0.000274	CcSEcCtD
Diclofenac—Hypersensitivity—Docetaxel—stomach cancer	3.39e-05	0.000273	CcSEcCtD
Diclofenac—Muscle spasms—Doxorubicin—stomach cancer	3.38e-05	0.000272	CcSEcCtD
Diclofenac—Palpitations—Epirubicin—stomach cancer	3.36e-05	0.000271	CcSEcCtD
Diclofenac—Confusional state—Methotrexate—stomach cancer	3.35e-05	0.000269	CcSEcCtD
Diclofenac—Loss of consciousness—Epirubicin—stomach cancer	3.34e-05	0.000269	CcSEcCtD
Diclofenac—Cough—Epirubicin—stomach cancer	3.32e-05	0.000267	CcSEcCtD
Diclofenac—Anaphylactic shock—Methotrexate—stomach cancer	3.32e-05	0.000267	CcSEcCtD
Diclofenac—Vision blurred—Doxorubicin—stomach cancer	3.32e-05	0.000267	CcSEcCtD
Diclofenac—Asthenia—Docetaxel—stomach cancer	3.3e-05	0.000266	CcSEcCtD
Diclofenac—Convulsion—Epirubicin—stomach cancer	3.3e-05	0.000265	CcSEcCtD
Diclofenac—Infection—Methotrexate—stomach cancer	3.3e-05	0.000265	CcSEcCtD
Diclofenac—Hypertension—Epirubicin—stomach cancer	3.28e-05	0.000264	CcSEcCtD
Diclofenac—Hypersensitivity—Capecitabine—stomach cancer	3.28e-05	0.000264	CcSEcCtD
Diclofenac—Ill-defined disorder—Doxorubicin—stomach cancer	3.27e-05	0.000263	CcSEcCtD
Diclofenac—Pruritus—Docetaxel—stomach cancer	3.26e-05	0.000262	CcSEcCtD
Diclofenac—Nervous system disorder—Methotrexate—stomach cancer	3.25e-05	0.000262	CcSEcCtD
Diclofenac—Anaemia—Doxorubicin—stomach cancer	3.25e-05	0.000262	CcSEcCtD
Diclofenac—Thrombocytopenia—Methotrexate—stomach cancer	3.25e-05	0.000262	CcSEcCtD
Diclofenac—Myalgia—Epirubicin—stomach cancer	3.24e-05	0.000261	CcSEcCtD
Diclofenac—Chest pain—Epirubicin—stomach cancer	3.24e-05	0.000261	CcSEcCtD
Diclofenac—Arthralgia—Epirubicin—stomach cancer	3.24e-05	0.000261	CcSEcCtD
Diclofenac—Agitation—Doxorubicin—stomach cancer	3.24e-05	0.00026	CcSEcCtD
Diclofenac—Anxiety—Epirubicin—stomach cancer	3.23e-05	0.00026	CcSEcCtD
Diclofenac—Skin disorder—Methotrexate—stomach cancer	3.22e-05	0.000259	CcSEcCtD
Diclofenac—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	3.22e-05	0.000259	CcSEcCtD
Diclofenac—Hyperhidrosis—Methotrexate—stomach cancer	3.21e-05	0.000258	CcSEcCtD
Diclofenac—Discomfort—Epirubicin—stomach cancer	3.2e-05	0.000258	CcSEcCtD
Diclofenac—Asthenia—Capecitabine—stomach cancer	3.2e-05	0.000257	CcSEcCtD
Diclofenac—Malaise—Doxorubicin—stomach cancer	3.17e-05	0.000256	CcSEcCtD
Diclofenac—Dry mouth—Epirubicin—stomach cancer	3.17e-05	0.000255	CcSEcCtD
Diclofenac—Vertigo—Doxorubicin—stomach cancer	3.16e-05	0.000255	CcSEcCtD
Diclofenac—Anorexia—Methotrexate—stomach cancer	3.16e-05	0.000255	CcSEcCtD
Diclofenac—Syncope—Doxorubicin—stomach cancer	3.16e-05	0.000254	CcSEcCtD
Diclofenac—Pruritus—Capecitabine—stomach cancer	3.15e-05	0.000254	CcSEcCtD
Diclofenac—Leukopenia—Doxorubicin—stomach cancer	3.15e-05	0.000254	CcSEcCtD
Diclofenac—Diarrhoea—Docetaxel—stomach cancer	3.15e-05	0.000254	CcSEcCtD
Diclofenac—Confusional state—Epirubicin—stomach cancer	3.13e-05	0.000252	CcSEcCtD
Diclofenac—Palpitations—Doxorubicin—stomach cancer	3.11e-05	0.00025	CcSEcCtD
Diclofenac—Anaphylactic shock—Epirubicin—stomach cancer	3.11e-05	0.00025	CcSEcCtD
Diclofenac—Oedema—Epirubicin—stomach cancer	3.11e-05	0.00025	CcSEcCtD
Diclofenac—Hypotension—Methotrexate—stomach cancer	3.1e-05	0.00025	CcSEcCtD
Diclofenac—Loss of consciousness—Doxorubicin—stomach cancer	3.09e-05	0.000249	CcSEcCtD
Diclofenac—Infection—Epirubicin—stomach cancer	3.08e-05	0.000248	CcSEcCtD
Diclofenac—Cough—Doxorubicin—stomach cancer	3.07e-05	0.000247	CcSEcCtD
Diclofenac—Shock—Epirubicin—stomach cancer	3.05e-05	0.000246	CcSEcCtD
Diclofenac—Convulsion—Doxorubicin—stomach cancer	3.05e-05	0.000246	CcSEcCtD
Diclofenac—Diarrhoea—Capecitabine—stomach cancer	3.05e-05	0.000246	CcSEcCtD
Diclofenac—Nervous system disorder—Epirubicin—stomach cancer	3.05e-05	0.000245	CcSEcCtD
Diclofenac—Dizziness—Docetaxel—stomach cancer	3.04e-05	0.000245	CcSEcCtD
Diclofenac—Thrombocytopenia—Epirubicin—stomach cancer	3.04e-05	0.000245	CcSEcCtD
Diclofenac—Hypertension—Doxorubicin—stomach cancer	3.04e-05	0.000245	CcSEcCtD
Diclofenac—Tachycardia—Epirubicin—stomach cancer	3.03e-05	0.000244	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Methotrexate—stomach cancer	3.02e-05	0.000243	CcSEcCtD
Diclofenac—Skin disorder—Epirubicin—stomach cancer	3.02e-05	0.000243	CcSEcCtD
Diclofenac—Hyperhidrosis—Epirubicin—stomach cancer	3e-05	0.000242	CcSEcCtD
Diclofenac—Insomnia—Methotrexate—stomach cancer	3e-05	0.000242	CcSEcCtD
Diclofenac—Arthralgia—Doxorubicin—stomach cancer	3e-05	0.000241	CcSEcCtD
Diclofenac—Chest pain—Doxorubicin—stomach cancer	3e-05	0.000241	CcSEcCtD
Diclofenac—Myalgia—Doxorubicin—stomach cancer	3e-05	0.000241	CcSEcCtD
Diclofenac—Anxiety—Doxorubicin—stomach cancer	2.99e-05	0.00024	CcSEcCtD
Diclofenac—Paraesthesia—Methotrexate—stomach cancer	2.98e-05	0.00024	CcSEcCtD
Diclofenac—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	2.98e-05	0.00024	CcSEcCtD
Diclofenac—Discomfort—Doxorubicin—stomach cancer	2.96e-05	0.000238	CcSEcCtD
Diclofenac—Anorexia—Epirubicin—stomach cancer	2.96e-05	0.000238	CcSEcCtD
Diclofenac—Dyspnoea—Methotrexate—stomach cancer	2.96e-05	0.000238	CcSEcCtD
Diclofenac—Somnolence—Methotrexate—stomach cancer	2.95e-05	0.000237	CcSEcCtD
Diclofenac—Dizziness—Capecitabine—stomach cancer	2.95e-05	0.000237	CcSEcCtD
Diclofenac—Dry mouth—Doxorubicin—stomach cancer	2.93e-05	0.000236	CcSEcCtD
Diclofenac—Vomiting—Docetaxel—stomach cancer	2.93e-05	0.000236	CcSEcCtD
Diclofenac—Dyspepsia—Methotrexate—stomach cancer	2.92e-05	0.000235	CcSEcCtD
Diclofenac—Rash—Docetaxel—stomach cancer	2.9e-05	0.000234	CcSEcCtD
Diclofenac—Hypotension—Epirubicin—stomach cancer	2.9e-05	0.000234	CcSEcCtD
Diclofenac—Dermatitis—Docetaxel—stomach cancer	2.9e-05	0.000233	CcSEcCtD
Diclofenac—Confusional state—Doxorubicin—stomach cancer	2.9e-05	0.000233	CcSEcCtD
Diclofenac—Decreased appetite—Methotrexate—stomach cancer	2.88e-05	0.000232	CcSEcCtD
Diclofenac—Headache—Docetaxel—stomach cancer	2.88e-05	0.000232	CcSEcCtD
Diclofenac—Anaphylactic shock—Doxorubicin—stomach cancer	2.87e-05	0.000231	CcSEcCtD
Diclofenac—Oedema—Doxorubicin—stomach cancer	2.87e-05	0.000231	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Methotrexate—stomach cancer	2.86e-05	0.000231	CcSEcCtD
Diclofenac—Fatigue—Methotrexate—stomach cancer	2.86e-05	0.00023	CcSEcCtD
Diclofenac—Infection—Doxorubicin—stomach cancer	2.85e-05	0.00023	CcSEcCtD
Diclofenac—Pain—Methotrexate—stomach cancer	2.84e-05	0.000228	CcSEcCtD
Diclofenac—Vomiting—Capecitabine—stomach cancer	2.83e-05	0.000228	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Epirubicin—stomach cancer	2.83e-05	0.000228	CcSEcCtD
Diclofenac—Shock—Doxorubicin—stomach cancer	2.83e-05	0.000228	CcSEcCtD
Diclofenac—Nervous system disorder—Doxorubicin—stomach cancer	2.82e-05	0.000227	CcSEcCtD
Diclofenac—Thrombocytopenia—Doxorubicin—stomach cancer	2.81e-05	0.000226	CcSEcCtD
Diclofenac—Rash—Capecitabine—stomach cancer	2.81e-05	0.000226	CcSEcCtD
Diclofenac—Insomnia—Epirubicin—stomach cancer	2.81e-05	0.000226	CcSEcCtD
Diclofenac—Dermatitis—Capecitabine—stomach cancer	2.81e-05	0.000226	CcSEcCtD
Diclofenac—Tachycardia—Doxorubicin—stomach cancer	2.8e-05	0.000226	CcSEcCtD
Diclofenac—Headache—Capecitabine—stomach cancer	2.79e-05	0.000225	CcSEcCtD
Diclofenac—Skin disorder—Doxorubicin—stomach cancer	2.79e-05	0.000225	CcSEcCtD
Diclofenac—Paraesthesia—Epirubicin—stomach cancer	2.79e-05	0.000224	CcSEcCtD
Diclofenac—Hyperhidrosis—Doxorubicin—stomach cancer	2.78e-05	0.000224	CcSEcCtD
Diclofenac—Dyspnoea—Epirubicin—stomach cancer	2.77e-05	0.000223	CcSEcCtD
Diclofenac—Somnolence—Epirubicin—stomach cancer	2.76e-05	0.000222	CcSEcCtD
Diclofenac—Anorexia—Doxorubicin—stomach cancer	2.74e-05	0.00022	CcSEcCtD
Diclofenac—Nausea—Docetaxel—stomach cancer	2.73e-05	0.00022	CcSEcCtD
Diclofenac—Feeling abnormal—Methotrexate—stomach cancer	2.73e-05	0.00022	CcSEcCtD
Diclofenac—Dyspepsia—Epirubicin—stomach cancer	2.73e-05	0.00022	CcSEcCtD
Diclofenac—Gastrointestinal pain—Methotrexate—stomach cancer	2.71e-05	0.000218	CcSEcCtD
Diclofenac—Decreased appetite—Epirubicin—stomach cancer	2.7e-05	0.000217	CcSEcCtD
Diclofenac—Hypotension—Doxorubicin—stomach cancer	2.68e-05	0.000216	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Epirubicin—stomach cancer	2.68e-05	0.000216	CcSEcCtD
Diclofenac—Fatigue—Epirubicin—stomach cancer	2.68e-05	0.000216	CcSEcCtD
Diclofenac—Pain—Epirubicin—stomach cancer	2.66e-05	0.000214	CcSEcCtD
Diclofenac—Constipation—Epirubicin—stomach cancer	2.66e-05	0.000214	CcSEcCtD
Diclofenac—Nausea—Capecitabine—stomach cancer	2.65e-05	0.000213	CcSEcCtD
Diclofenac—Urticaria—Methotrexate—stomach cancer	2.64e-05	0.000212	CcSEcCtD
Diclofenac—Body temperature increased—Methotrexate—stomach cancer	2.62e-05	0.000211	CcSEcCtD
Diclofenac—Abdominal pain—Methotrexate—stomach cancer	2.62e-05	0.000211	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Doxorubicin—stomach cancer	2.62e-05	0.000211	CcSEcCtD
Diclofenac—Insomnia—Doxorubicin—stomach cancer	2.6e-05	0.000209	CcSEcCtD
Diclofenac—Paraesthesia—Doxorubicin—stomach cancer	2.58e-05	0.000208	CcSEcCtD
Diclofenac—Dyspnoea—Doxorubicin—stomach cancer	2.56e-05	0.000206	CcSEcCtD
Diclofenac—Feeling abnormal—Epirubicin—stomach cancer	2.56e-05	0.000206	CcSEcCtD
Diclofenac—Somnolence—Doxorubicin—stomach cancer	2.55e-05	0.000206	CcSEcCtD
Diclofenac—Gastrointestinal pain—Epirubicin—stomach cancer	2.54e-05	0.000204	CcSEcCtD
Diclofenac—Dyspepsia—Doxorubicin—stomach cancer	2.53e-05	0.000204	CcSEcCtD
Diclofenac—Decreased appetite—Doxorubicin—stomach cancer	2.5e-05	0.000201	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Doxorubicin—stomach cancer	2.48e-05	0.0002	CcSEcCtD
Diclofenac—Fatigue—Doxorubicin—stomach cancer	2.48e-05	0.000199	CcSEcCtD
Diclofenac—Urticaria—Epirubicin—stomach cancer	2.47e-05	0.000199	CcSEcCtD
Diclofenac—Pain—Doxorubicin—stomach cancer	2.46e-05	0.000198	CcSEcCtD
Diclofenac—Constipation—Doxorubicin—stomach cancer	2.46e-05	0.000198	CcSEcCtD
Diclofenac—Abdominal pain—Epirubicin—stomach cancer	2.45e-05	0.000198	CcSEcCtD
Diclofenac—Body temperature increased—Epirubicin—stomach cancer	2.45e-05	0.000198	CcSEcCtD
Diclofenac—Hypersensitivity—Methotrexate—stomach cancer	2.44e-05	0.000197	CcSEcCtD
Diclofenac—Asthenia—Methotrexate—stomach cancer	2.38e-05	0.000192	CcSEcCtD
Diclofenac—Feeling abnormal—Doxorubicin—stomach cancer	2.37e-05	0.000191	CcSEcCtD
Diclofenac—Gastrointestinal pain—Doxorubicin—stomach cancer	2.35e-05	0.000189	CcSEcCtD
Diclofenac—Pruritus—Methotrexate—stomach cancer	2.35e-05	0.000189	CcSEcCtD
Diclofenac—Hypersensitivity—Epirubicin—stomach cancer	2.29e-05	0.000184	CcSEcCtD
Diclofenac—Urticaria—Doxorubicin—stomach cancer	2.28e-05	0.000184	CcSEcCtD
Diclofenac—Abdominal pain—Doxorubicin—stomach cancer	2.27e-05	0.000183	CcSEcCtD
Diclofenac—Body temperature increased—Doxorubicin—stomach cancer	2.27e-05	0.000183	CcSEcCtD
Diclofenac—Diarrhoea—Methotrexate—stomach cancer	2.27e-05	0.000183	CcSEcCtD
Diclofenac—Asthenia—Epirubicin—stomach cancer	2.23e-05	0.000179	CcSEcCtD
Diclofenac—Pruritus—Epirubicin—stomach cancer	2.2e-05	0.000177	CcSEcCtD
Diclofenac—Dizziness—Methotrexate—stomach cancer	2.19e-05	0.000177	CcSEcCtD
Diclofenac—Diarrhoea—Epirubicin—stomach cancer	2.12e-05	0.000171	CcSEcCtD
Diclofenac—Hypersensitivity—Doxorubicin—stomach cancer	2.12e-05	0.00017	CcSEcCtD
Diclofenac—Vomiting—Methotrexate—stomach cancer	2.11e-05	0.00017	CcSEcCtD
Diclofenac—Rash—Methotrexate—stomach cancer	2.09e-05	0.000168	CcSEcCtD
Diclofenac—Dermatitis—Methotrexate—stomach cancer	2.09e-05	0.000168	CcSEcCtD
Diclofenac—Headache—Methotrexate—stomach cancer	2.08e-05	0.000167	CcSEcCtD
Diclofenac—Asthenia—Doxorubicin—stomach cancer	2.06e-05	0.000166	CcSEcCtD
Diclofenac—Dizziness—Epirubicin—stomach cancer	2.05e-05	0.000165	CcSEcCtD
Diclofenac—Pruritus—Doxorubicin—stomach cancer	2.03e-05	0.000164	CcSEcCtD
Diclofenac—Vomiting—Epirubicin—stomach cancer	1.97e-05	0.000159	CcSEcCtD
Diclofenac—Nausea—Methotrexate—stomach cancer	1.97e-05	0.000159	CcSEcCtD
Diclofenac—Diarrhoea—Doxorubicin—stomach cancer	1.97e-05	0.000158	CcSEcCtD
Diclofenac—Rash—Epirubicin—stomach cancer	1.96e-05	0.000158	CcSEcCtD
Diclofenac—Dermatitis—Epirubicin—stomach cancer	1.96e-05	0.000157	CcSEcCtD
Diclofenac—Headache—Epirubicin—stomach cancer	1.95e-05	0.000157	CcSEcCtD
Diclofenac—Dizziness—Doxorubicin—stomach cancer	1.9e-05	0.000153	CcSEcCtD
Diclofenac—Nausea—Epirubicin—stomach cancer	1.84e-05	0.000148	CcSEcCtD
Diclofenac—Vomiting—Doxorubicin—stomach cancer	1.83e-05	0.000147	CcSEcCtD
Diclofenac—Rash—Doxorubicin—stomach cancer	1.81e-05	0.000146	CcSEcCtD
Diclofenac—Dermatitis—Doxorubicin—stomach cancer	1.81e-05	0.000146	CcSEcCtD
Diclofenac—Headache—Doxorubicin—stomach cancer	1.8e-05	0.000145	CcSEcCtD
Diclofenac—Nausea—Doxorubicin—stomach cancer	1.71e-05	0.000137	CcSEcCtD
Diclofenac—CXCL8—Signaling by GPCR—IL6—stomach cancer	2.51e-06	2.87e-05	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—PIK3CA—stomach cancer	2.5e-06	2.86e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PPP2R1A—stomach cancer	2.49e-06	2.85e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	2.48e-06	2.84e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—TYMP—stomach cancer	2.47e-06	2.83e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—FADS1—stomach cancer	2.47e-06	2.83e-05	CbGpPWpGaD
Diclofenac—ABCB1—Transmembrane transport of small molecules—ALB—stomach cancer	2.47e-06	2.83e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—ENO1—stomach cancer	2.46e-06	2.82e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—CAV1—stomach cancer	2.46e-06	2.82e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—CCND1—stomach cancer	2.46e-06	2.82e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—TYMS—stomach cancer	2.46e-06	2.82e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—APOA1—stomach cancer	2.46e-06	2.81e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—JUN—stomach cancer	2.45e-06	2.81e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—GSTP1—stomach cancer	2.44e-06	2.8e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—GSTM1—stomach cancer	2.43e-06	2.78e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—ALB—stomach cancer	2.43e-06	2.78e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—ALB—stomach cancer	2.42e-06	2.78e-05	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—TP53—stomach cancer	2.41e-06	2.77e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—NOS3—stomach cancer	2.41e-06	2.76e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—HMOX1—stomach cancer	2.41e-06	2.76e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—TYMS—stomach cancer	2.41e-06	2.76e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—CDKN1B—stomach cancer	2.4e-06	2.75e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—CD44—stomach cancer	2.4e-06	2.74e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—MMP9—stomach cancer	2.39e-06	2.73e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—GSTM1—stomach cancer	2.38e-06	2.73e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—CDKN1A—stomach cancer	2.38e-06	2.72e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—ERCC2—stomach cancer	2.38e-06	2.72e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—CD44—stomach cancer	2.34e-06	2.68e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—IL6ST—stomach cancer	2.33e-06	2.67e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	2.32e-06	2.66e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—NOS3—stomach cancer	2.32e-06	2.66e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—MAPK8—stomach cancer	2.32e-06	2.66e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—SREBF2—stomach cancer	2.31e-06	2.65e-05	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—HRAS—stomach cancer	2.31e-06	2.65e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	2.3e-06	2.64e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—RORA—stomach cancer	2.29e-06	2.62e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—ERCC2—stomach cancer	2.28e-06	2.62e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PPARG—stomach cancer	2.28e-06	2.62e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PPP2R1A—stomach cancer	2.28e-06	2.61e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—TYMS—stomach cancer	2.27e-06	2.6e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PPP2R1A—stomach cancer	2.27e-06	2.6e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—GSTT1—stomach cancer	2.25e-06	2.57e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—GSTM1—stomach cancer	2.24e-06	2.57e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—APC—stomach cancer	2.24e-06	2.57e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—VEGFA—stomach cancer	2.24e-06	2.57e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—GSTP1—stomach cancer	2.24e-06	2.56e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—ERCC2—stomach cancer	2.24e-06	2.56e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—MTHFR—stomach cancer	2.23e-06	2.56e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—GSTP1—stomach cancer	2.23e-06	2.55e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—CYP2A6—stomach cancer	2.22e-06	2.54e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—CDKN1A—stomach cancer	2.22e-06	2.54e-05	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—IL6—stomach cancer	2.21e-06	2.53e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—HMOX1—stomach cancer	2.21e-06	2.53e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—PTGS2—stomach cancer	2.2e-06	2.52e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—HMOX1—stomach cancer	2.2e-06	2.52e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—CD44—stomach cancer	2.18e-06	2.5e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—AKR1C3—stomach cancer	2.16e-06	2.47e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—MTHFR—stomach cancer	2.15e-06	2.46e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—ALDOB—stomach cancer	2.14e-06	2.46e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—VEGFA—stomach cancer	2.14e-06	2.46e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—PTGS2—stomach cancer	2.12e-06	2.43e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—STAT3—stomach cancer	2.12e-06	2.43e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	2.12e-06	2.43e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—MAPK3—stomach cancer	2.12e-06	2.43e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—ERCC2—stomach cancer	2.11e-06	2.42e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—ENO1—stomach cancer	2.1e-06	2.41e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—MTHFR—stomach cancer	2.1e-06	2.41e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—IL6R—stomach cancer	2.08e-06	2.38e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—TYMS—stomach cancer	2.08e-06	2.38e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—ALB—stomach cancer	2.07e-06	2.37e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—TYMS—stomach cancer	2.07e-06	2.37e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—CAV1—stomach cancer	2.06e-06	2.36e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—GSTM1—stomach cancer	2.06e-06	2.36e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—APOA1—stomach cancer	2.06e-06	2.36e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—ALB—stomach cancer	2.05e-06	2.35e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—GSTM1—stomach cancer	2.05e-06	2.34e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PPP2R1A—stomach cancer	2.04e-06	2.33e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—MAPK3—stomach cancer	2.03e-06	2.32e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—MAPK1—stomach cancer	2.02e-06	2.31e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—GSTP1—stomach cancer	2e-06	2.29e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—ALOX5—stomach cancer	1.99e-06	2.28e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PPP2R1A—stomach cancer	1.99e-06	2.28e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—MTHFR—stomach cancer	1.98e-06	2.27e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—CAV1—stomach cancer	1.98e-06	2.27e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—STAT3—stomach cancer	1.98e-06	2.27e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—APOA1—stomach cancer	1.98e-06	2.26e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—MYC—stomach cancer	1.97e-06	2.26e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—HMOX1—stomach cancer	1.97e-06	2.26e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.97e-06	2.26e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—NOS3—stomach cancer	1.96e-06	2.25e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—DPYD—stomach cancer	1.96e-06	2.25e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—GSTP1—stomach cancer	1.95e-06	2.23e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—SERPINE1—stomach cancer	1.95e-06	2.23e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—CAV1—stomach cancer	1.94e-06	2.22e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—APOA1—stomach cancer	1.94e-06	2.22e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—ERCC2—stomach cancer	1.93e-06	2.22e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—MAPK1—stomach cancer	1.93e-06	2.21e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—EGFR—stomach cancer	1.93e-06	2.21e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—HMOX1—stomach cancer	1.92e-06	2.2e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—ERCC2—stomach cancer	1.92e-06	2.2e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—KRAS—stomach cancer	1.9e-06	2.18e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—MAPK3—stomach cancer	1.89e-06	2.17e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—RHOA—stomach cancer	1.88e-06	2.15e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—CD44—stomach cancer	1.87e-06	2.14e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—NOS3—stomach cancer	1.86e-06	2.13e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—TYMS—stomach cancer	1.86e-06	2.13e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PPP2R1A—stomach cancer	1.86e-06	2.13e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—MYC—stomach cancer	1.84e-06	2.11e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—GSTM1—stomach cancer	1.84e-06	2.1e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—CAV1—stomach cancer	1.83e-06	2.1e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—APOA1—stomach cancer	1.83e-06	2.09e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—KRAS—stomach cancer	1.82e-06	2.09e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—GSTP1—stomach cancer	1.82e-06	2.09e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—MTHFR—stomach cancer	1.82e-06	2.08e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—TYMS—stomach cancer	1.81e-06	2.08e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PPARG—stomach cancer	1.81e-06	2.08e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	1.81e-06	2.08e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—MTHFR—stomach cancer	1.81e-06	2.07e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—MAPK1—stomach cancer	1.8e-06	2.06e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—EGFR—stomach cancer	1.8e-06	2.06e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—HMOX1—stomach cancer	1.8e-06	2.06e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PTGS2—stomach cancer	1.8e-06	2.06e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—GSTM1—stomach cancer	1.79e-06	2.05e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—PIK3CA—stomach cancer	1.75e-06	2e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.75e-06	2e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PPARG—stomach cancer	1.74e-06	2e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—ERBB2—stomach cancer	1.74e-06	1.99e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—GSTT1—stomach cancer	1.73e-06	1.99e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—ERCC2—stomach cancer	1.73e-06	1.98e-05	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—PIK3CA—stomach cancer	1.71e-06	1.96e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CYP2A6—stomach cancer	1.71e-06	1.96e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PPARG—stomach cancer	1.71e-06	1.95e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—KRAS—stomach cancer	1.7e-06	1.95e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—TYMS—stomach cancer	1.69e-06	1.94e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—TP53—stomach cancer	1.69e-06	1.94e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—ERCC2—stomach cancer	1.69e-06	1.93e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—CAV1—stomach cancer	1.68e-06	1.92e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—GSTM1—stomach cancer	1.67e-06	1.92e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—PIK3CA—stomach cancer	1.67e-06	1.92e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—APOA1—stomach cancer	1.67e-06	1.92e-05	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—PIK3CA—stomach cancer	1.67e-06	1.91e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—CAV1—stomach cancer	1.67e-06	1.91e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—AKR1C3—stomach cancer	1.67e-06	1.91e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—APOA1—stomach cancer	1.66e-06	1.91e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—ALB—stomach cancer	1.63e-06	1.87e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—ENO1—stomach cancer	1.62e-06	1.86e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—MTHFR—stomach cancer	1.62e-06	1.86e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—TP53—stomach cancer	1.62e-06	1.86e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—HRAS—stomach cancer	1.62e-06	1.85e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—CDKN1B—stomach cancer	1.61e-06	1.85e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PPARG—stomach cancer	1.61e-06	1.84e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.6e-06	1.84e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.59e-06	1.83e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PPP2R1A—stomach cancer	1.59e-06	1.82e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—MTHFR—stomach cancer	1.58e-06	1.81e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—ERCC2—stomach cancer	1.57e-06	1.8e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—ALB—stomach cancer	1.57e-06	1.79e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—PIK3CA—stomach cancer	1.56e-06	1.79e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—NOS3—stomach cancer	1.56e-06	1.79e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—GSTP1—stomach cancer	1.56e-06	1.78e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—HRAS—stomach cancer	1.55e-06	1.77e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—HMOX1—stomach cancer	1.54e-06	1.76e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—ALB—stomach cancer	1.53e-06	1.76e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—NOS3—stomach cancer	1.5e-06	1.72e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—CAV1—stomach cancer	1.5e-06	1.72e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—APOA1—stomach cancer	1.49e-06	1.71e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—CDKN1A—stomach cancer	1.49e-06	1.7e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—IL6—stomach cancer	1.48e-06	1.7e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—MTHFR—stomach cancer	1.48e-06	1.7e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PPARG—stomach cancer	1.47e-06	1.69e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—NOS3—stomach cancer	1.47e-06	1.68e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PPARG—stomach cancer	1.47e-06	1.68e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—CAV1—stomach cancer	1.46e-06	1.67e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—APOA1—stomach cancer	1.46e-06	1.67e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—TYMS—stomach cancer	1.45e-06	1.66e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—ALB—stomach cancer	1.45e-06	1.66e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—HRAS—stomach cancer	1.44e-06	1.65e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CD44—stomach cancer	1.44e-06	1.65e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—GSTM1—stomach cancer	1.43e-06	1.64e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.43e-06	1.64e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—NOS3—stomach cancer	1.38e-06	1.58e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—IL6—stomach cancer	1.38e-06	1.58e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PTGS2—stomach cancer	1.37e-06	1.57e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—CAV1—stomach cancer	1.36e-06	1.56e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—APOA1—stomach cancer	1.36e-06	1.56e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—PIK3CA—stomach cancer	1.36e-06	1.55e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—ERCC2—stomach cancer	1.35e-06	1.54e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PTGS2—stomach cancer	1.34e-06	1.54e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—STAT3—stomach cancer	1.33e-06	1.52e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—ALB—stomach cancer	1.33e-06	1.52e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PPARG—stomach cancer	1.32e-06	1.51e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—PIK3CA—stomach cancer	1.31e-06	1.5e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.3e-06	1.49e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PPARG—stomach cancer	1.28e-06	1.47e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—MAPK3—stomach cancer	1.27e-06	1.45e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—NOS3—stomach cancer	1.27e-06	1.45e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PTGS2—stomach cancer	1.27e-06	1.45e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—MTHFR—stomach cancer	1.26e-06	1.45e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—NOS3—stomach cancer	1.26e-06	1.44e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—MYC—stomach cancer	1.23e-06	1.41e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PPP2R1A—stomach cancer	1.23e-06	1.4e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—MAPK1—stomach cancer	1.21e-06	1.38e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—EGFR—stomach cancer	1.21e-06	1.38e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—GSTP1—stomach cancer	1.2e-06	1.38e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PPARG—stomach cancer	1.2e-06	1.37e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—HMOX1—stomach cancer	1.19e-06	1.36e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—ALB—stomach cancer	1.18e-06	1.36e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—CAV1—stomach cancer	1.17e-06	1.34e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—APOA1—stomach cancer	1.16e-06	1.33e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PTGS2—stomach cancer	1.16e-06	1.33e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—ALB—stomach cancer	1.15e-06	1.32e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PTGS2—stomach cancer	1.15e-06	1.32e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—KRAS—stomach cancer	1.14e-06	1.31e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—NOS3—stomach cancer	1.13e-06	1.3e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—TYMS—stomach cancer	1.12e-06	1.28e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.11e-06	1.28e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—NOS3—stomach cancer	1.1e-06	1.27e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PIK3CA—stomach cancer	1.1e-06	1.27e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—GSTM1—stomach cancer	1.1e-06	1.27e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—ALB—stomach cancer	1.08e-06	1.24e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—PIK3CA—stomach cancer	1.05e-06	1.2e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—ERCC2—stomach cancer	1.04e-06	1.19e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PTGS2—stomach cancer	1.04e-06	1.19e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—NOS3—stomach cancer	1.03e-06	1.18e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PPARG—stomach cancer	1.03e-06	1.17e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PTGS2—stomach cancer	1.01e-06	1.16e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—MTHFR—stomach cancer	9.76e-07	1.12e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—HRAS—stomach cancer	9.69e-07	1.11e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PTGS2—stomach cancer	9.44e-07	1.08e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—IL6—stomach cancer	9.27e-07	1.06e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—ALB—stomach cancer	9.22e-07	1.06e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CAV1—stomach cancer	9e-07	1.03e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—APOA1—stomach cancer	8.98e-07	1.03e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—NOS3—stomach cancer	8.82e-07	1.01e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PIK3CA—stomach cancer	8.77e-07	1e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PIK3CA—stomach cancer	8.43e-07	9.66e-06	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PIK3CA—stomach cancer	8.26e-07	9.46e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PTGS2—stomach cancer	8.07e-07	9.24e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PPARG—stomach cancer	7.91e-07	9.07e-06	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PIK3CA—stomach cancer	7.78e-07	8.92e-06	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PIK3CA—stomach cancer	7.14e-07	8.18e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—ALB—stomach cancer	7.12e-07	8.15e-06	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PIK3CA—stomach cancer	7.09e-07	8.13e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—NOS3—stomach cancer	6.81e-07	7.8e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PIK3CA—stomach cancer	6.37e-07	7.3e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PTGS2—stomach cancer	6.23e-07	7.13e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PIK3CA—stomach cancer	6.22e-07	7.12e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PIK3CA—stomach cancer	5.81e-07	6.65e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PIK3CA—stomach cancer	4.96e-07	5.69e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PIK3CA—stomach cancer	3.83e-07	4.39e-06	CbGpPWpGaD
